Clinical Microbiology and Antimicrobial Chemotherapy.2004; 6(3):273-281
Historically, intravenous immunoglobulins (ivIg) were initially used as replacement therapy in patients with antibody deficiency disorders.Later on ivIg were suggested to have advantages in treatment of patients with autoimmune and systemic …